{"id":477,"date":"2026-08-28T06:56:06","date_gmt":"2026-08-28T06:56:06","guid":{"rendered":"https:\/\/nhdbio.com\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary\/"},"modified":"2026-08-28T07:31:46","modified_gmt":"2026-08-28T07:31:46","slug":"aod-9604-gh-fragmento-evidencia-regulatorio-y-limite-de-calidad","status":"publish","type":"post","link":"https:\/\/nhdbio.com\/es\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary\/","title":{"rendered":"L\u00edmite de evidencia de AOD-9604: biolog\u00eda del fragmento de GH, desarrollo fallido e identidad del lote"},"content":{"rendered":"<p class=\"pim-standfirst wp-block-paragraph\">AOD-9604 es un fragmento modificado de la hormona del crecimiento desarrollado en torno a una hip\u00f3tesis de lip\u00f3lisis. La plausibilidad precl\u00ednica y el desarrollo temprano no anulan el ensayo nulo sobre obesidad m\u00e1s amplio.<\/p><div class=\"wp-block-group pim-key-takeaways\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\"><h2 class=\"wp-block-heading\">Lo que muestra el registro<\/h2><ul class=\"wp-block-list\"><li>El historial de eficacia humana es m\u00e1s d\u00e9bil de lo que implican muchos res\u00famenes de productos.<\/li><li>ClinicalTrials.gov no conten\u00eda estudios de AOD-9604 en la b\u00fasqueda 2024 de FDA.<\/li><li>La identidad de secuencia\/forma y las pruebas de lote no pueden establecer un efecto terap\u00e9utico.<\/li><\/ul><\/div><\/div><figure class=\"wp-block-image size-full pim-article-figure\"><img loading=\"lazy\" decoding=\"async\" width=\"1536\" height=\"1024\" src=\"http:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/gh-secretagogue-research-20260828.png\" alt=\"Cient\u00edfico revisando datos de investigaci\u00f3n sobre la hormona de crecimiento puls\u00e1til y IGF-1\" class=\"wp-image-459\" srcset=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/gh-secretagogue-research-20260828.png 1536w, https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/gh-secretagogue-research-20260828-300x200.png 300w, https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/gh-secretagogue-research-20260828-1024x683.png 1024w, https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/gh-secretagogue-research-20260828-768x512.png 768w\" sizes=\"auto, (max-width: 1536px) 100vw, 1536px\" \/><figcaption class=\"wp-element-caption\">Ilustraci\u00f3n editorial original utilizada para identificar el tema de la investigaci\u00f3n. No representa un lote de cat\u00e1logo, medicamento aprobado, resultado de ensayo o uso cl\u00ednico.<\/figcaption><\/figure><h2 class=\"wp-block-heading\">La frontera entre identidad y evidencia<\/h2><p class=\"wp-block-paragraph\">Una p\u00e1gina de material puede discutir con precisi\u00f3n la identidad de secuencia, los m\u00e9todos anal\u00edticos y la hip\u00f3tesis de la investigaci\u00f3n hist\u00f3rica. Tambi\u00e9n deber\u00eda salir a la luz el nulo resultado de desarrollo junto a cualquier menci\u00f3n de la investigaci\u00f3n sobre la p\u00e9rdida de peso.<\/p><div class=\"wp-block-group pim-evidence-table\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\"><div class=\"pim-evidence-row\"><strong>Origen mecanicista<\/strong><span>Fragmento GH modificado estudiado en modelos metab\u00f3licos<\/span><\/div><div class=\"pim-evidence-row\"><strong>Problema de evidencia humana<\/strong><span>Gran estudio clave nulo y no publicado en su totalidad en una revista<\/span><\/div><div class=\"pim-evidence-row\"><strong>L\u00edmite de reclamo<\/strong><span>No se ha establecido eficacia cl\u00ednica para la p\u00e9rdida de peso.<\/span><\/div><\/div><\/div><h2 class=\"wp-block-heading\">Qu\u00e9 pertenece al registro de materiales<\/h2><p class=\"wp-block-paragraph\">Para la revisi\u00f3n del lote, confirme la secuencia, la forma molecular, la masa, el m\u00e9todo de pureza, el contenido cuantitativo de p\u00e9ptidos y el enlace del lote. Esos controles establecen la caracterizaci\u00f3n del material, no la eficacia cl\u00ednica.<\/p><h2 class=\"wp-block-heading\">Regla editorial<\/h2><p class=\"wp-block-paragraph\">Utilice el nombre exacto de la intervenci\u00f3n, el modelo, la poblaci\u00f3n y el criterio de valoraci\u00f3n del registro citado. No convierta una asociaci\u00f3n, mecanismo, resultado en animales, registro de medicamento terminado aprobado o prueba anal\u00edtica en una afirmaci\u00f3n sobre un lote de cat\u00e1logo no relacionado.<\/p>","protected":false},"excerpt":{"rendered":"<p>AOD-9604 es un fragmento modificado de la hormona del crecimiento desarrollado en torno a una hip\u00f3tesis de lip\u00f3lisis. La plausibilidad precl\u00ednica y el desarrollo temprano no anulan el ensayo nulo sobre obesidad m\u00e1s amplio.<\/p>","protected":false},"author":1,"featured_media":642,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"pim_family_ids":"314","pim_article_type":"Evidence and material-quality guide","pim_evidence_level":"Preclinical mechanism, incomplete clinical publication and FDA review","pim_reviewer":"NHD evidence editorial workflow","pim_reviewed_date":"2026-08-28","pim_editorial_note":"Source-checked on 2026-08-28. Null findings and study limitations are retained. This is not independent peer review, medical advice, a customer case, or validation of a catalog lot.","pim_review_status":"reviewed","pim_review_reason":"At least two linked primary or authoritative records and an explicit evidence boundary are present.","pim_creation_method":"The editorial workflow starts with linked peer-reviewed papers, trial registries or regulatory records; extracts the population or model, endpoints, numerical results and limitations; and separates the studied intervention from catalog material. AI-assisted drafting was used to structure the first version. Claims, figures, evidence labels and limitations were checked against the linked records in the site editorial workflow. This is not independent peer review.","pim_sources":"[{\"title\":\"FDA December 2024 AOD-9604 briefing document\",\"url\":\"https:\/\/www.fda.gov\/media\/183584\/download\",\"note\":\"FDA review of effectiveness, safety and the OPTIONS result.\"},{\"title\":\"AOD-9604 development review\",\"url\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/15134286\/\",\"note\":\"Contemporaneous development summary; PMID 15134286.\"},{\"title\":\"FDA December 2024 PCAC meeting record\",\"url\":\"https:\/\/www.fda.gov\/advisory-committees\/advisory-committee-calendar\/updated-meeting-time-and-public-participation-information-december-4-2024-meeting-pharmacy\",\"note\":\"Regulatory meeting context.\"}]","footnotes":""},"categories":[20],"tags":[],"class_list":["post-477","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-evidence-quality-guides"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.0 (Yoast SEO v28.1) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>AOD-9604 Evidence, Development &amp; Quality Boundaries<\/title>\n<meta name=\"description\" content=\"AOD-9604 is a modified growth-hormone fragment developed around a lipolysis hypothesis. Preclinical plausibility and early development do not override the\u2026\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nhdbio.com\/es\/aod-9604-gh-fragmento-evidencia-regulatorio-y-limite-de-calidad\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AOD-9604 Evidence Boundary: GH Fragment Biology, Failed Development and Lot Identity\" \/>\n<meta property=\"og:description\" content=\"AOD-9604 is a modified growth-hormone fragment developed around a lipolysis hypothesis. Preclinical plausibility and early development do not override the\u2026\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nhdbio.com\/es\/aod-9604-gh-fragmento-evidencia-regulatorio-y-limite-de-calidad\/\" \/>\n<meta property=\"og:site_name\" content=\"NHD\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-28T06:56:06+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-28T07:31:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary-featured-v2.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1536\" \/>\n\t<meta property=\"og:image:height\" content=\"960\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"NHD Technical Team\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Peptide Raw Materials and Custom Peptide Synthesis\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"NHD Technical Team\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary\\\/\"},\"author\":{\"name\":\"NHD Technical Team\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\"},\"headline\":\"AOD-9604 Evidence Boundary: GH Fragment Biology, Failed Development and Lot Identity\",\"datePublished\":\"2026-08-28T06:56:06+00:00\",\"dateModified\":\"2026-08-28T07:31:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary\\\/\"},\"wordCount\":227,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary-featured-v2.webp\",\"articleSection\":[\"Evidence &amp; Quality Guides\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary\\\/\",\"name\":\"AOD-9604 Evidence, Development & Quality Boundaries\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary-featured-v2.webp\",\"datePublished\":\"2026-08-28T06:56:06+00:00\",\"dateModified\":\"2026-08-28T07:31:46+00:00\",\"description\":\"AOD-9604 is a modified growth-hormone fragment developed around a lipolysis hypothesis. Preclinical plausibility and early development do not override the\u2026\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary-featured-v2.webp\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary-featured-v2.webp\",\"width\":1536,\"height\":960,\"caption\":\"Article-specific editorial image.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nhdbio.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AOD-9604 Evidence Boundary: GH Fragment Biology, Failed Development and Lot Identity\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"name\":\"NHD\",\"description\":\"Peptide Raw Materials and Custom Peptide Synthesis\",\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nhdbio.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\",\"name\":\"NHD\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"width\":2172,\"height\":724,\"caption\":\"NHD\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\",\"name\":\"NHD Technical Team\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"caption\":\"NHD Technical Team\"},\"description\":\"NHD Technical Team maintains research-use catalog documentation and evidence summaries. Reviewed articles link to peer-reviewed papers, trial registries and regulatory records, retain null findings and study limitations, and distinguish published interventions from catalog materials. AI-assisted drafting may be used for structure; source links and evidence boundaries remain visible. This work is not independent peer review or medical advice.\",\"sameAs\":[\"https:\\\/\\\/nhdbio.com\"],\"url\":\"https:\\\/\\\/nhdbio.com\\\/es\\\/author\\\/qianmiao-technical-team\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"AOD-9604 L\u00edmites de evidencia, desarrollo y calidad","description":"AOD-9604 es un fragmento modificado de la hormona del crecimiento desarrollado en torno a una hip\u00f3tesis de lip\u00f3lisis. La plausibilidad precl\u00ednica y el desarrollo temprano no anulan la...","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nhdbio.com\/es\/aod-9604-gh-fragmento-evidencia-regulatorio-y-limite-de-calidad\/","og_locale":"es_ES","og_type":"article","og_title":"AOD-9604 Evidence Boundary: GH Fragment Biology, Failed Development and Lot Identity","og_description":"AOD-9604 is a modified growth-hormone fragment developed around a lipolysis hypothesis. Preclinical plausibility and early development do not override the\u2026","og_url":"https:\/\/nhdbio.com\/es\/aod-9604-gh-fragmento-evidencia-regulatorio-y-limite-de-calidad\/","og_site_name":"NHD","article_published_time":"2026-08-28T06:56:06+00:00","article_modified_time":"2026-08-28T07:31:46+00:00","og_image":[{"width":1536,"height":960,"url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary-featured-v2.webp","type":"image\/webp"}],"author":"NHD Technical Team","twitter_card":"summary_large_image","twitter_description":"Peptide Raw Materials and Custom Peptide Synthesis","twitter_misc":{"Escrito por":"NHD Technical Team","Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nhdbio.com\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary\/#article","isPartOf":{"@id":"https:\/\/nhdbio.com\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary\/"},"author":{"name":"NHD Technical Team","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1"},"headline":"AOD-9604 Evidence Boundary: GH Fragment Biology, Failed Development and Lot Identity","datePublished":"2026-08-28T06:56:06+00:00","dateModified":"2026-08-28T07:31:46+00:00","mainEntityOfPage":{"@id":"https:\/\/nhdbio.com\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary\/"},"wordCount":227,"commentCount":0,"publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"image":{"@id":"https:\/\/nhdbio.com\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary-featured-v2.webp","articleSection":["Evidence &amp; Quality Guides"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/nhdbio.com\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/nhdbio.com\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary\/","url":"https:\/\/nhdbio.com\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary\/","name":"AOD-9604 L\u00edmites de evidencia, desarrollo y calidad","isPartOf":{"@id":"https:\/\/nhdbio.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nhdbio.com\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary\/#primaryimage"},"image":{"@id":"https:\/\/nhdbio.com\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary-featured-v2.webp","datePublished":"2026-08-28T06:56:06+00:00","dateModified":"2026-08-28T07:31:46+00:00","description":"AOD-9604 es un fragmento modificado de la hormona del crecimiento desarrollado en torno a una hip\u00f3tesis de lip\u00f3lisis. La plausibilidad precl\u00ednica y el desarrollo temprano no anulan la...","breadcrumb":{"@id":"https:\/\/nhdbio.com\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nhdbio.com\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/nhdbio.com\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary\/#primaryimage","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary-featured-v2.webp","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary-featured-v2.webp","width":1536,"height":960,"caption":"Article-specific editorial image."},{"@type":"BreadcrumbList","@id":"https:\/\/nhdbio.com\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nhdbio.com\/"},{"@type":"ListItem","position":2,"name":"AOD-9604 Evidence Boundary: GH Fragment Biology, Failed Development and Lot Identity"}]},{"@type":"WebSite","@id":"https:\/\/nhdbio.com\/#website","url":"https:\/\/nhdbio.com\/","name":"NHD","description":"Materias primas pept\u00eddicas y s\u00edntesis personalizada","publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nhdbio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/nhdbio.com\/#organization","name":"NHD","url":"https:\/\/nhdbio.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","width":2172,"height":724,"caption":"NHD"},"image":{"@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1","name":"Equipo t\u00e9cnico de NHD","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","caption":"NHD Technical Team"},"description":"El equipo t\u00e9cnico de NHD mantiene documentaci\u00f3n del cat\u00e1logo de uso de investigaci\u00f3n y res\u00famenes de evidencia. Los art\u00edculos revisados \u200b\u200benlazan con art\u00edculos revisados \u200b\u200bpor pares, registros de ensayos y registros regulatorios, conservan hallazgos nulos y limitaciones de estudios, y distinguen las intervenciones publicadas de los materiales del cat\u00e1logo. Se puede utilizar dibujo asistido por AI para la estructura; los enlaces de fuentes y los l\u00edmites de las pruebas permanecen visibles. Este trabajo no es una revisi\u00f3n por pares independiente ni un consejo m\u00e9dico.","sameAs":["https:\/\/nhdbio.com"],"url":"https:\/\/nhdbio.com\/es\/author\/qianmiao-technical-team\/"}]}},"_links":{"self":[{"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/posts\/477","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/comments?post=477"}],"version-history":[{"count":1,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/posts\/477\/revisions"}],"predecessor-version":[{"id":499,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/posts\/477\/revisions\/499"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/media\/642"}],"wp:attachment":[{"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/media?parent=477"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/categories?post=477"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/tags?post=477"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}